Join us as we speak with Dr. Aaron Goldberg from Memorial Sloan Kettering Cancer Center in New York City. Dr. Goldberg discusses how secondary AML differs from AML and how treatment is determined. Secondary AML is a diagnosis of AML that has occurred after previous exposure to radiation or chemotherapy for another cancer or has evolved from a prior diagnosis of MDS, MPN or Aplastic Anemia. In this episode, Dr. Goldberg points out the major difference between secondary AML and de novo AML and new, promising treatments.
Podcast: Play in new window | Download
Subscribe: Spotify | Pandora | Blubrry | JioSaavn | Podchaser | More
CLICK HERE to participate in our episode survey.Mentioned on this Episode:
- Acute myeloid leukemia (AML)
- Integrative Medicine Service
- Stem Cell Transplantation
- Myelodysplastic syndrome (MDS)
- Myeloproliferative neoplasms (MPN)
Additional LLS Support Resources:
- Information Specialists
- Free telephone/web patient programs
- Free booklets
- Financial support
- Online chats
- Caregiver support
- LLS Community
- Support groups
- Patti Robinson Kaufmann First Connection Program
- Free Nutrition Consultations
- Understanding Secondary AML Webcast
Support for this episode provided by Jazz Pharmaceuticals.